novo nordisk fda - Search News

FDA Declares Shortage of Novo Nordisk's Wegovy, Ozempic

Hosted on MSN · 2d

FDA Declares Shortage of Novo Nordisk’s Wegovy, Ozempic Over

The FDA announcement confirms that the U.S. supply of both prescription-only drugs now meets or exceeds the current and projected demand in the country, the Danish pharmaceutical company said.

The Washington Post on MSN · 2d

FDA says Ozempic shortage is over, chilling boom in off-brand versions

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the end to the booming market for cheaper versions made by pharmacies.

CNN on MSN · 2d

Ozempic and Wegovy are no longer in shortage, FDA says

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

1h

Semaglutide shortage ends as FDA sets deadline for compounders

With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions of semaglutide are no longer allowed ...

4h

Wall Street Thinks This Weight-Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk

Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Lilly now ranks as ...

5d

Novo Nordisk alleges fraud after $1.3 billion deal to buy hypertension drug from KBP Biosciences

Novo Nordisk is seeking up to $830 million in damages from KBP Biosciences, according to a ruling by a Singapore court, as ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results